"Blood Coagulation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.
| Descriptor ID |
D001777
|
| MeSH Number(s) |
G09.188.390.150
|
| Concept/Terms |
Blood Coagulation- Blood Coagulation
- Blood Clotting
- Blood Clottings
- Clotting, Blood
- Coagulation, Blood
|
Below are MeSH descriptors whose meaning is more general than "Blood Coagulation".
Below are MeSH descriptors whose meaning is more specific than "Blood Coagulation".
This graph shows the total number of publications written about "Blood Coagulation" by people in this website by year, and whether "Blood Coagulation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 1 | 3 |
| 2022 | 0 | 2 | 2 |
| 2023 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Coagulation" by people in Profiles.
-
Dumas A, Goyal N, Mottamal M, Afosah DK, Al-Horani RA. Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors. J Thromb Thrombolysis. 2024 Dec; 57(8):1308-1314.
-
Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023 03 22; 12.
-
Al-Horani RA, Afosah DK, Mottamal M. Triazol-1-yl Benzamides Promote Anticoagulant Activity via Inhibition of Factor XIIa. Cardiovasc Hematol Agents Med Chem. 2023; 21(2):108-119.
-
Kar S, Vu K, Mottamal M, Al-Horani RA. Ethacrynic acid is an inhibitor of human factor XIIIa. BMC Pharmacol Toxicol. 2022 06 01; 23(1):35.
-
Al-Horani RA, Parsaeian E, Mohammad M, Mottamal M. Sulfonated non-saccharide molecules and human factor XIa: Enzyme inhibition and computational studies. Chem Biol Drug Des. 2022 07; 100(1):64-79.
-
Wang J, Zuo Y, Zhuang K, Luo K, Yan X, Li J, Zhang JH, Liu F. Recombinant Human Milk Fat Globule-Epidermal Growth Factor 8 Attenuates Microthrombosis after Subarachnoid Hemorrhage in Rats. J Stroke Cerebrovasc Dis. 2020 Mar; 29(3):104536.
-
Al-Horani RA, Clemons D, Mottamal M. The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis. Molecules. 2019 Jun 06; 24(11).
-
Park J, Choi EK, Han KD, Choi YJ, Lee E, Choe W, Lee SR, Cha MJ, Lim WH, Kang J, Park KW, Oh S, Lip GYH. Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study. PLoS One. 2019; 14(1):e0209593.
-
Coleman CI, Vaitsiakhovich T, Nguyen E, Weeda ER, Sood NA, Bunz TJ, Schaefer B, Meinecke AK, Eriksson D. Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients. Clin Cardiol. 2018 Jan; 41(1):119-125.
-
Kim J, Nafiujjaman M, Nurunnabi M, Lim S, Lee YK, Park HK. Effects of polymer-coated boron nitrides with increased hemorheological compatibility on human erythrocytes and blood coagulation. Clin Hemorheol Microcirc. 2018; 70(3):241-256.